日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma

功能性转录组图谱为多发性骨髓瘤的治疗策略提供信息

Sudalagunta, Praneeth Reddy; Canevarolo, Rafael R; Meads, Mark B; Silva, Maria; Zhao, Xiaohong; Cubitt, Christopher L; Sansil, Samer S; DeAvila, Gabriel; Alugubelli, Raghunandan Reddy; Bishop, Ryan T; Tungesvik, Alexandre; Zhang, Qi; Hampton, Oliver; Teer, Jamie K; Welsh, Eric A; Yoder, Sean J; Shah, Bijal D; Hazlehurst, Lori; Gatenby, Robert A; Van Domelen, Dane R; Chai, Yi; Wang, Feng; DeCastro, Andrew; Bloomer, Amanda M; Siegel, Erin M; Lynch, Conor C; Sullivan, Daniel M; Alsina, Melissa; Nishihori, Taiga; Brayer, Jason; Cleveland, John L; Dalton, William; Walker, Christopher J; Landesman, Yosef; Baz, Rachid; Silva, Ariosto S; Shain, Kenneth H

Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.

表观遗传可塑性驱动多发性骨髓瘤的致癌作用和多重治疗耐药性

Renatino Canevarolo Rafael, Sudalagunta Praneeth Reddy, Meads Mark B, Silva Maria, Zhao Xiaohong, Magaletti Dario, Alugubelli Raghunandan Reddy, DeAvila Gabriel, Persi Erez, Maura Francesco, Bell Elissa T, Bishop Ryan T, Cubitt Christopher L, Sansil Samer S, Zhang Wei, Teer Jamie K, Teng Mingxiang, Yoder Sean J, Siegel Erin M, Shah Bijal D, Nishihori Taiga, Hazlehurst Lori A, Lynch Conor C, Landgren Ola, Hampton Oliver, Gatenby Robert A, Sullivan Daniel M, Brayer Jason B, Dalton William S, Cleveland John L, Alsina Melissa, Baz Rachid, Shain Kenneth H, Silva Ariosto Siqueira

Lenalidomide-based response-adapted therapy for older adults without high risk myeloma

针对非高危多发性骨髓瘤老年患者的以来那度胺为基础的反应适应性治疗

Baz, Rachid; Naqvi, Syeda Mahrukh Hussnain; Lee, Jae-Hoon; Brayer, Jason; Hillgruber, Nancy; Fridley, Brooke L; Shain, Kenneth H; Sullivan, Daniel M; Alsina, Melissa

A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer

一项腺病毒-p53转导树突状细胞疫苗联合吲哚莫德治疗转移性实体瘤和浸润性乳腺癌的I/II期研究

Soliman, Hatem; Khambati, Fatema; Han, Hyo S; Ismail-Khan, Roohi; Bui, Marilyn M; Sullivan, Daniel M; Antonia, Scott

Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors

采用XPO1抑制剂和拓扑异构酶II抑制剂联合疗法治疗多发性骨髓瘤获得性耐药

Turner, Joel G; Dawson, Jana L; Grant, Steven; Shain, Kenneth H; Dalton, William S; Dai, Yun; Meads, Mark; Baz, Rachid; Kauffman, Michael; Shacham, Sharon; Sullivan, Daniel M

A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer

利西替尼(OSI-906)与拓扑替康治疗复发性小细胞肺癌患者的随机II期研究

Chiappori, Alberto A; Otterson, Gregory A; Dowlati, Afshin; Traynor, Anne M; Horn, Leora; Owonikoko, Taofeek K; Ross, Helen J; Hann, Christine L; Abu Hejleh, Taher; Nieva, Jorge; Zhao, Xiuhua; Schell, Michael; Sullivan, Daniel M

A phase I study of indoximod in patients with advanced malignancies

一项针对晚期恶性肿瘤患者的吲哚莫德 I 期研究

Soliman, Hatem H; Minton, Susan E; Han, Hyo Sook; Ismail-Khan, Roohi; Neuger, Anthony; Khambati, Fatema; Noyes, David; Lush, Richard; Chiappori, Alberto A; Roberts, John D; Link, Charles; Vahanian, Nicholas N; Mautino, Mario; Streicher, Howard; Sullivan, Daniel M; Antonia, Scott J

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

口服 AKT 抑制剂 MK-2206 联合卡铂/紫杉醇、多西他赛或厄洛替尼治疗晚期实体瘤患者的 1 期临床试验

Molife, L Rhoda; Yan, Li; Vitfell-Rasmussen, Joanna; Zernhelt, Adriane M; Sullivan, Daniel M; Cassier, Philippe A; Chen, Eric; Biondo, Andrea; Tetteh, Ernestina; Siu, Lillian L; Patnaik, Amita; Papadopoulos, Kyriakos P; de Bono, Johann S; Tolcher, Anthony W; Minton, Susan

Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents

抑制CRM1依赖性核输出可使恶性细胞对细胞毒性药物和靶向药物更加敏感。

Turner, Joel G; Dawson, Jana; Cubitt, Christopher L; Baz, Rachid; Sullivan, Daniel M

Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma

聚乙二醇化脂质体阿霉素、低剂量地塞米松和来那度胺治疗新诊断多发性骨髓瘤患者的II期研究

Baz, Rachid C; Shain, Kenneth H; Hussein, Mohamad A; Lee, Ji-Hyun; Sullivan, Daniel M; Oliver, Elizabeth Finley; Nardelli, Lisa A; Nodzon, Lisa A; Zhao, Xiuhua; Ochoa-Bayona, Jose Leonel; Nishihori, Taiga; Dalton, William S; Alsina, Melissa